Oral bioavailability and in vitro stability of pivampicillin, bacampicillin, talampicillin, and ampicillin in horses. 1996

J M Ensink, and A G Vulto, and A S van Miert, and J J Tukker, and M B Winkel, and M A Fluitman
Department of General and Large Animal Surgery, Utrecht University, The Netherlands.

OBJECTIVE To determine the oral bioavailabilities of 3 ampicillin esters (pivampicillin, bacampicillin, and talampicillin) and ampicillin sodium, and to determine in vitro stability of the ampicillin esters in ileal contents (pH 8.3 to 8.5). METHODS A crossover design to administer the 4 drugs orally, and ampicillin i.v. to all horses in the study. METHODS 4 healthy adult horses. METHODS The drugs were administered intragastrically to the horses at a dosage equimolar to 15 mg of ampicillin/kg of body weight. Also, ampicillin sodium was administered i.v. at the same dosage. Blood samples were taken up to 12 hours after drug administration, and ampicillin concentrations in plasma were determined. For the in vitro study, the ampicillin esters were incubated at 37 C in ileal contents obtained from ponies with cecal fistulas. After incubation, the remaining intact ester and the formed ampicillin were measured. RESULTS Absolute oral bioavailability was 31, 39, 23, and 2% for pivampicillin, bacampicillin, talampicillin, and ampicillin sodium, respectively. In the in vitro study, 90% decomposition of the ester took place in 30, 60, and 5 minutes, for pivampicillin, bacampicillin, and talampicillin, respectively. CONCLUSIONS Pivampicillin and bacampicillin are promising candidates for oral antibiotic treatment of horses. The rapid decomposition of ampicillin esters is caused by chemical hydrolysis at the high pH of equine ileal contents.

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D008297 Male Males
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D009919 Orchiectomy The surgical removal of one or both testicles. Castration, Male,Orchidectomy,Castrations, Male,Male Castration,Male Castrations,Orchidectomies,Orchiectomies
D010406 Penicillins A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065) Antibiotics, Penicillin,Penicillin,Penicillin Antibiotics
D010917 Pivampicillin Pivalate ester analog of AMPICILLIN. Ampicillin Pivaloyl Ester,Berocillin,Pivamiser,Pivampicillin Hydrochloride,Pivampicillin Monohydrochloride,Pondocillin,Ester, Ampicillin Pivaloyl,Hydrochloride, Pivampicillin,Monohydrochloride, Pivampicillin
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006736 Horses Large, hoofed mammals of the family EQUIDAE. Horses are active day and night with most of the day spent seeking and consuming food. Feeding peaks occur in the early morning and late afternoon, and there are several daily periods of rest. Equus caballus,Equus przewalskii,Horse, Domestic,Domestic Horse,Domestic Horses,Horse,Horses, Domestic

Related Publications

J M Ensink, and A G Vulto, and A S van Miert, and J J Tukker, and M B Winkel, and M A Fluitman
December 1981, Antimicrobial agents and chemotherapy,
J M Ensink, and A G Vulto, and A S van Miert, and J J Tukker, and M B Winkel, and M A Fluitman
September 1981, Drug and therapeutics bulletin,
J M Ensink, and A G Vulto, and A S van Miert, and J J Tukker, and M B Winkel, and M A Fluitman
October 1979, Journal of pharmacokinetics and biopharmaceutics,
J M Ensink, and A G Vulto, and A S van Miert, and J J Tukker, and M B Winkel, and M A Fluitman
January 1978, Antimicrobial agents and chemotherapy,
J M Ensink, and A G Vulto, and A S van Miert, and J J Tukker, and M B Winkel, and M A Fluitman
January 1983, Pharmatherapeutica,
J M Ensink, and A G Vulto, and A S van Miert, and J J Tukker, and M B Winkel, and M A Fluitman
January 1979, Infection,
J M Ensink, and A G Vulto, and A S van Miert, and J J Tukker, and M B Winkel, and M A Fluitman
July 1989, Drug and therapeutics bulletin,
J M Ensink, and A G Vulto, and A S van Miert, and J J Tukker, and M B Winkel, and M A Fluitman
June 1978, Antimicrobial agents and chemotherapy,
J M Ensink, and A G Vulto, and A S van Miert, and J J Tukker, and M B Winkel, and M A Fluitman
September 1976, The Journal of antimicrobial chemotherapy,
J M Ensink, and A G Vulto, and A S van Miert, and J J Tukker, and M B Winkel, and M A Fluitman
February 1975, MMW, Munchener medizinische Wochenschrift,
Copied contents to your clipboard!